RESULTS: Dermatological assessment was performed in 251 IBD patients [115 females, age 47 [16-85]; IBD duration 9 years [1-46]]: 158 Crohn's disease [CD] [63%], 93 ulcerative colitis [UC] [37%]. Psoriasis was detected in 62 [25%] IBD patients: 36 [58%] CD, 26 UC [42%; p = 0.44]. Clinical characteristics were comparable between IBD patients with or without psoriasis: age 50 [23-72] vs 47 [16-85]; IBD duration 9.5 [1-46] vs 9 [1-41]; p = non-significant]. The non-IBD group included 62 patients with psoriasis: 35 male; age 47 [18-75]. Mild psoriasis was more frequent in IBD vs non-IBD [87% vs 53%; p < 0.0001], whereas moderate and severe psoriasis were more frequent in non-IBD vs IBD [37% vs 13%, p = 0.004; 10% vs 0%; p = 0.036]. Plaque-type p...
Psoriasis and inflammatory bowel disease (IBD) are immune-mediated diseases occurring in barrier org...
Psoriasis is a chronic inflammatory skin disease, the prevalence of which is around 1.5 % to 4.7% in...
© 2020 American Academy of Dermatology, Inc. Background: Information on the real-world risk of infla...
RESULTS: Dermatological assessment was performed in 251 IBD patients [115 females, age 47 [16-85]; I...
RESULTS: Dermatological assessment was performed in 251 IBD patients [115 females, age 47 [16-85]; I...
BACKGROUND: Psoriasis and inflammatory bowel diseases (IBD) share common pathways based on immune...
BACKGROUND: There is a significant association between psoriasis and inflammatory bowel disease (IBD...
Abstract Psoriasis is more common in patients with inflammatory bowel disease (IBD) than in the gene...
8Background: Psoriasis and inflammatory bowel diseases share common immunological pathomechanisms an...
Extra-intestinal manifestations are a relatively common complications of Inflammatory Bowel Diseases...
BACKGROUND: Several studies linked various chronic inflammatory skin diseases (CISDs) with inflammat...
Psoriasis and inflammatory bowel disease (IBD) are multifactorial chronic immuno-inflammatory potent...
Background: Paradoxical cases of psoriatic lesions induced or exacerbated by anti-tumor necrosis fac...
Observational studies have suggested an association between inflammatory bowel disease [IBD] and pso...
Psoriasis induced by anti-tumor necrosis factor-α (TNF) therapy has been described as a paradoxical ...
Psoriasis and inflammatory bowel disease (IBD) are immune-mediated diseases occurring in barrier org...
Psoriasis is a chronic inflammatory skin disease, the prevalence of which is around 1.5 % to 4.7% in...
© 2020 American Academy of Dermatology, Inc. Background: Information on the real-world risk of infla...
RESULTS: Dermatological assessment was performed in 251 IBD patients [115 females, age 47 [16-85]; I...
RESULTS: Dermatological assessment was performed in 251 IBD patients [115 females, age 47 [16-85]; I...
BACKGROUND: Psoriasis and inflammatory bowel diseases (IBD) share common pathways based on immune...
BACKGROUND: There is a significant association between psoriasis and inflammatory bowel disease (IBD...
Abstract Psoriasis is more common in patients with inflammatory bowel disease (IBD) than in the gene...
8Background: Psoriasis and inflammatory bowel diseases share common immunological pathomechanisms an...
Extra-intestinal manifestations are a relatively common complications of Inflammatory Bowel Diseases...
BACKGROUND: Several studies linked various chronic inflammatory skin diseases (CISDs) with inflammat...
Psoriasis and inflammatory bowel disease (IBD) are multifactorial chronic immuno-inflammatory potent...
Background: Paradoxical cases of psoriatic lesions induced or exacerbated by anti-tumor necrosis fac...
Observational studies have suggested an association between inflammatory bowel disease [IBD] and pso...
Psoriasis induced by anti-tumor necrosis factor-α (TNF) therapy has been described as a paradoxical ...
Psoriasis and inflammatory bowel disease (IBD) are immune-mediated diseases occurring in barrier org...
Psoriasis is a chronic inflammatory skin disease, the prevalence of which is around 1.5 % to 4.7% in...
© 2020 American Academy of Dermatology, Inc. Background: Information on the real-world risk of infla...